Search filters

List of works by Clément Morgat

68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate Cancer

scientific article published on 01 September 2019

A phantom-based method to standardize dose-calibrators for new β+-emitters.

scientific article

Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists

scientific article published on 6 October 2017

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples

scientific article published in PLoS ONE

Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples.

scientific article published on 3 June 2019

Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides

scientific article published on 02 March 2020

Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy

scientific article published on 09 February 2016

Early use of abiraterone and radium-223 in metastatic prostate cancer

scientific article published on 01 May 2019

Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors.

scientific article published on 9 March 2017

Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases

scientific article published on 07 April 2019

Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging.

scientific article published on 10 March 2017

Somatostatin Antagonists for Radioligand Therapy of Nonendocrine Tumors

scientific article published on 17 August 2017